Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus

Journal of Diabetes and Metabolic Disorders

Volumn 12, Issue 1, 2013, Pages

  Edalat, Banoo ^a   Sharifi, Farshad ^a,b   Badamchizadeh, Zohre ^a   Hossein Nezhad, Arash ^a   Larijani, Bagher ^a   Mirarefin, Mojde ^a   Fakhrzadeh, Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PHD of Geriatric Epidemiology   (Iran)

Author keywords

Diabetes gestational; Inflammation mediators; Metabolic syndrome X

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6;

ADULT; AGE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREGNANCY DIABETES MELLITUS; PREVALENCE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; AGE DISTRIBUTION; DISEASE CLASSIFICATION; HEALTH SURVEY; INSULIN SENSITIVITY; LABORATORY TEST; PROTEIN ANALYSIS;

EID: 84882788647     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-12-8     Document Type: Article

References (34)

1. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005, 115:485-91. 1052018, 15765129.
2. Hossein-Nezhad A, Maghbooli Z, Vassigh AR. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol 2007, 46(3):236-241. 10.1016/S1028-4559(08)60026-1, 17962102.
3. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 2002, 25:1862-1868. 10.2337/diacare.25.10.1862, 12351492.
4. Metzger BE, Cho NH, Roston SM. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993, 16:1598-1605. 10.2337/diacare.16.12.1598, 8299456.
5. Feig DS, Zinman B, Wang X, Hux JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008, 179(3):229-234. 2474881, 18663202.
6. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979, 241:2035-8. 10.1001/jama.1979.03290450033020, 430798.
7. Di Cianni G, Lencioni C, Volpe L. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 2007, 23(2):135-140. 10.1002/dmrr.661, 16770838.
8. Ferraz TB, Motta RS, Ferraz CL. C-reactive protein and components of metabolic syndrome in Brazilian women with previous gestational diabetes. Diabetes Res Clin Pract 2007, 78(1):23-29. 10.1016/j.diabres.2007.01.025, 17449131.
9. Wolf M, Sandler L, Hsu K. First- trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003, 26(3):819-24. 10.2337/diacare.26.3.819, 12610043.
10. Barzilay JI, Abraham L, Heckbert SR. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001, 50:2384-2389. 10.2337/diabetes.50.10.2384, 11574423.
11. Pradhan AD, Cook NR, Buring JE. C-reactive protein is independently associated with fasting insulin in non diabetic women. Arterioscler Thromb Vasc Biol 2003, 23(4):650-655. 10.1161/01.ATV.0000065636.15310.9C, 12692007.
12. Visser M, Bouter LM, McQuillan GM. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1998, 282(22):2131-2135.
13. Jassal DS, Blair O. The Impact of C-Reactive Protein. Perspective in Cardiol 2003, 19(2):30-36.
14. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005, 54(Suppl 2):S114-124.
15. Dubiński A, Zdrojewicz Z. [The role of interleukin-6 in development and progression of atherosclerosis]" (in Polish). Pol Merkur Lekarski 2007, 22(130):291-294.
16. Pradhan AD, Manson JE, Rifai N. C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. JAMA 2001, 286(3):327-334. 10.1001/jama.286.3.327, 11466099.
17. Grundy SM, Brewer HB, Cleeman JI. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109(3):433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958.
18. Haffner MS, Gonzalez C, Miettiner H. A prospective analysis of the HOMA model. Diabetes Care 1996, 19:1138-1141. 10.2337/diacare.19.10.1138, 8886564.
19. Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003, 108(12):e81-85. 10.1161/01.CIR.0000093381.57779.67, 14504253.
20. Isomaa B, Forsén B, Lahti K. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia 2010, 53(8):1709-1713. 10.1007/s00125-010-1776-y, 20454776.
21. Verma A, Boney CM, Tucker R. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002, 87(7):3227-3235. 10.1210/jc.87.7.3227, 12107230.
22. Akinci B, Celtik A, Yener S. Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 2010, 93(4):1248-1254. 10.1016/j.fertnstert.2008.12.007, 19147138.
23. Chatzi L, Plana E, Pappas A. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes Metab 2009, 35(6):490-494. 10.1016/j.diabet.2009.07.003, 19897394.
24. Lauenborg J, Mathiesen E, Hansen T. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005, 90(7):4004-4010. 10.1210/jc.2004-1713, 15840755.
25. Winzer C, Wagner O, Festa A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004, 27(7):1721-1727. 10.2337/diacare.27.7.1721, 15220253.
26. Kao TW, Lu IS, Liao KC. Associations between body mass index and serum levels of C-reactive protein. S Afr Med J 2009, 99(5):326-330.
27. Retnakaran R, Hanley AG, Raif N. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003, 88(8):3507-3512. 10.1210/jc.2003-030186, 12915627.
28. Saltevo J, Vanhala M, Kautiainen H. Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with the relative change in body mass index between childhood and adulthood. Diab Vasc Dis Res 2007, 4(4):328-331. 10.3132/dvdr.2007.060, 18158703.
29. King DE, Mainous AG, Buchanan TA. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 2003, 26(5):1535-1539. 10.2337/diacare.26.5.1535, 12716818.
30. Lee AJ, Hiscock RJ, Wein P. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007, 30(4):878-883. 10.2337/dc06-1816, 17392549.
31. Niskanen L, Laaksonen DE, Nyyssönen K. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004, 44(6):859-865. 10.1161/01.HYP.0000146691.51307.84, 15492131.
32. Cartier A. The inflammatory profile associated with abdominal obesity. Official J International Chair on Cardiometabolic Risk 2010, 3(2):15-19.
33. Alvehus M, Burén J, Sjöström M. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010, 18(5):879-883.
34. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B. [Obesity as inflammatory disease]. Postepy Hig Med Dosw (Online) 2008, 27; 62:249-257. Review.